Baseline NT‐proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation

BACKGROUND: Up to 30% of patients undergoing transcatheter aortic valve implantation (TAVI) experience minimal symptomatic benefit or die within 1 year, indicating an urgent need for enhanced patient selection. Previous analyses of baseline NT‐proBNP (N‐terminal pro‐brain natriuretic peptide) and TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Christopher J., Joseph, Jubin, Patterson, Tiffany, Hammond‐Haley, Matthew, McConkey, Hannah Z. R., Prendergast, Bernard D., Marber, Michael, Redwood, Simon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763793/
https://www.ncbi.nlm.nih.gov/pubmed/33241754
http://dx.doi.org/10.1161/JAHA.120.017574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763793/
https://www.ncbi.nlm.nih.gov/pubmed/33241754
http://dx.doi.org/10.1161/JAHA.120.017574

Ejemplares similares